Refractory Mood Disorders Program

The Refractory Mood Disorders Program, part of the Center of Excellence on Mood Disorders, leads research in the development of innovative treatment options for refractory mood disorders. Refractory, also known as treatment-resistant, describes conditions that do not respond to at least two different medications.

Led by  Salih Selek, MD, our team is currently involved in the following research:

• Magnetic Seizure Therapy (MST) Project

The purpose of this study is to determine the effectiveness of MST in bipolar depression and to compare the side effects of magnetic seizure therapy (MST) and electroconvulsive therapy (ECT). Link: https://clinicaltrials.gov/ct2/show/NCT04080778